Hot High Tech Stocks To Buy For 2019


U.S. stock-index futures pointed to a higher open on Wednesday, suggesting the Dow could climb back above the 26,000 level as major indexes looked to trade within striking distance of record levels.

The corporate earnings season continue to be a primary driver of trading, with financial heavyweights in particular view.

What are the main benchmarks doing?

Dow Jones Industrial Average futures
YMH8, +0.52%
were up by 115 points, or 0.5%, to 25,934, while S&P 500 futures
ESH8, +0.40%
added 9.40 points, or 0.3%, to 2,792. Nasdaq-100 futures
NQH8, +0.46%
tacked on 21.50 points, or 0.3%, to 6,783.75.

Hot High Tech Stocks To Buy For 2019: Regal Entertainment Group(RGC)


Advisors’ Opinion:

  • [By Peter Graham]

    In December, UK based Cineworld Group Plc also agreed tobuy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in adeal to create the world’s second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Hot High Tech Stocks To Buy For 2019: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot High Tech Stocks To Buy For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 15.66 million, compared to the previous 15.25 million. The stock was trading at $91.36, in a 52-week range of $64.61 to $125.86.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

Hot High Tech Stocks To Buy For 2019: Nuveen Premium Income Municipal Fund, Inc.(NPI)


Advisors’ Opinion:

  • [By Logan Wallace]

    Northland Power (TSE:NPI) is set to release its earnings data after the market closes on Wednesday, May 9th. Analysts expect Northland Power to post earnings of C$0.45 per share for the quarter.

Hot High Tech Stocks To Buy For 2019: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By ]

    In his second “Executive Decision” segment, Cramer sat down with Jean-Jacques Bienaime, chairman and CEO of orphan drugmaker BioMarin Pharmaceuticals Inc.  (BMRN) , to discuss what’s coming down the company’s pipeline.

  • [By Joseph Griffin]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get BioMarin Pharmaceutical alerts:

    BioMarin Pharmaceutical (BMRN) Director Sells $318,750.00 in Stock (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) BioMarin Pharmaceutical’s (BMRN) “Outperform” Rating Reiterated at BMO Capital Markets (americanbankingnews.com) Three healthcare stocks driving the gene therapy momentum (ca.finance.yahoo.com) 4 Red-Hot Biotech Stocks to Buy Before Earnings (247wallst.com)


    Shares of BioMarin Pharmaceutical stock traded down $1.32 on Friday, hitting $82.30. 2,278,721 shares of the company’s stock traded hands, compared to its average volume of 1,207,934. BioMarin Pharmaceutical has a one year low of $75.81 and a one year high of $100.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.70 and a quick ratio of 2.12. The firm has a market cap of $14,490.73, a price-to-earnings ratio of -122.84 and a beta of 1.69.

Hot High Tech Stocks To Buy For 2019: EQT Corporation(EQT)


Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was EQT Corp. (NYSE: EQT) which rose about 10% to $53.35. The stocks 52-week range is $43.70 to $67.84. Volume was nearly 11 million compared to the daily average volume of 3.6 million.

  • [By ]

    In addition, Elliott Management, which often pushes for M&A and other strategic transactions at targeted companies, made investments in EQT Corp. (EQT) , CommVault Systems Inc. (CVLT) , Sabre Corp. (SABR) , Teradyne Inc. (TER)  and Windstream Holdings Inc. (WIN)

  • [By Max Byerly]

    DekaBank Deutsche Girozentrale raised its stake in shares of EQT (NYSE:EQT) by 85.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 67,281 shares of the oil and gas producer’s stock after purchasing an additional 31,000 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in EQT were worth $3,219,000 at the end of the most recent reporting period.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was EQT Corp. (NYSE: EQT) which traded down over 5% at $49.72. The stocks 52-week range is $43.70 to $67.84. Volume was 7.6 million compared to the daily average volume of nearly 4 million.

Leave a Reply

Your email address will not be published.